Hunter's syndrome, also known as mucopolysaccharidosis type II (MPS II), is a rare and progressive genetic disorder with significant implications in patients. The disorder arises from a deficiency of the enzyme iduronate 2-sulfatase, leading to the abnormal accumulation of glycosaminoglycans in various tissues throughout the body. Early identificat